spectrin β IV Activators
Spectrin β IV activators encompass a diverse group of chemicals that, rather than directly interacting with spectrin β IV, modulate various signaling pathways and cellular processes which can indirectly influence the activity or functionality of spectrin β IV. These chemicals are characterized by their ability to modulate key cellular signaling molecules and pathways, such as adenylate cyclase, protein kinase C, calmodulin-dependent kinase, guanylate cyclase, phosphodiesterases, EGFR signaling, GSK-3β, ROCK, and various kinases.
The primary mechanism by which these activators influence spectrin β IV is through the modulation of the cytoskeletal network. The cytoskeleton, a complex and dynamic structure within the cell, is crucial for maintaining cell shape, enabling cellular movement, and facilitating intracellular transport. Spectrin β IV, being an integral component of the cytoskeletal matrix, is sensitive to changes in the overall architecture and dynamics of the cytoskeleton. The activators listed target various aspects of the cytoskeletal dynamics either by altering the phosphorylation state of key proteins, changing intracellular second messenger levels (like cAMP, cGMP, and calcium), or by influencing kinase activity. These alterations can lead to rearrangements in the cytoskeletal structure, thus indirectly affecting the role or positioning of spectrin β IV within the cell.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin is an activator of adenylate cyclase, leading to increased levels of cAMP. Higher cAMP levels can activate PKA, which can phosphorylate and regulate various proteins and pathways. This activation may modulate the cytoskeleton, potentially affecting spectrin β IV. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC). PKC is known to phosphorylate a wide range of proteins, influencing numerous cellular functions including the cytoskeletal arrangement. This can indirectly affect spectrin β IV by altering the structural dynamics of the cell. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 increases intracellular calcium levels. Elevated calcium can activate calmodulin-dependent kinase, which impacts cytoskeletal proteins. This alteration in the cytoskeletal network can indirectly influence the function or localization of spectrin β IV. | ||||||
Sodium nitroprusside dihydrate | 13755-38-9 | sc-203395 sc-203395A sc-203395B | 1 g 5 g 100 g | $43.00 $85.00 $158.00 | 7 | |
Sodium nitroprusside releases NO, which activates guanylate cyclase. This leads to increased cGMP levels, potentially affecting PKG and other kinases. These kinases could modify cytoskeletal components, thereby indirectly influencing spectrin β IV. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a non-selective inhibitor of phosphodiesterases, leading to increased levels of cAMP and cGMP. This results in the activation of PKA and PKG, respectively, potentially influencing the cytoskeletal dynamics and indirectly affecting spectrin β IV. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride inhibits GSK-3β, leading to altered signaling in the Wnt pathway. This can impact the cytoskeletal organization and potentially influence spectrin β IV. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y-27632 is a ROCK inhibitor. ROCK plays a crucial role in cytoskeletal dynamics. Inhibition of ROCK can lead to changes in the cellular structural framework, potentially affecting spectrin β IV. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a potent, non-selective inhibitor of protein kinases. Its wide-ranging effects on kinase activity can indirectly influence cytoskeletal proteins, including spectrin β IV. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein is a tyrosine kinase inhibitor. By modulating tyrosine kinase activity, it can affect several signaling pathways, potentially leading to changes in the cytoskeletal arrangement and influencing spectrin β IV. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a PI3K inhibitor. PI3K is involved in a variety of cellular processes, including those affecting the cytoskeleton. Inhibition of PI3K can indirectly impact spectrin β IV. | ||||||